zonisamide has been researched along with Deficiency, IgG in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "If patients with ZNS therapy showed IgA deficiency and recurrent infections, it is preferable to check serum IgG subclass concentrations as well." | 1.30 | IgA and IgG2 deficiency associated with zonisamide therapy: a case report. ( Dejima, S; Hara, T; Maeoka, Y; Takeshita, K, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeoka, Y | 1 |
| Hara, T | 1 |
| Dejima, S | 1 |
| Takeshita, K | 1 |
1 other study available for zonisamide and Deficiency, IgG
| Article | Year |
|---|---|
IgA and IgG2 deficiency associated with zonisamide therapy: a case report.
Topics: Anticonvulsants; Epilepsy; Humans; IgA Deficiency; IgG Deficiency; Immunoglobulin A; Immunoglobulin | 1997 |